A detailed history of Financial Architects, Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Financial Architects, Inc holds 1,975 shares of LLY stock, worth $1.57 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
1,975
Previous 2,362 16.38%
Holding current value
$1.57 Million
Previous $811,000 14.18%
% of portfolio
0.14%
Previous 0.13%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

SELL
$350.74 - $468.98 $135,736 - $181,495
-387 Reduced 16.38%
1,975 $926,000
Q1 2023

May 12, 2023

BUY
$310.63 - $364.82 $71,134 - $83,543
229 Added 10.74%
2,362 $811,000
Q4 2022

Feb 06, 2023

SELL
$321.55 - $374.67 $9,324 - $10,865
-29 Reduced 1.34%
2,133 $780,000
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $640,989 - $730,474
2,162 New
2,162 $699,000
Q2 2022

Aug 11, 2022

SELL
$278.73 - $327.27 $519,273 - $609,704
-1,863 Closed
0 $0
Q1 2022

May 05, 2022

BUY
$234.69 - $291.66 $264,260 - $328,409
1,126 Added 152.78%
1,863 $534,000
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $165,714 - $205,652
737 New
737 $204,000
Q3 2020

Nov 09, 2020

SELL
$146.22 - $169.13 $99,283 - $114,839
-679 Closed
0 $0
Q2 2020

Aug 11, 2020

BUY
$136.42 - $164.18 $9,412 - $11,328
69 Added 11.31%
679 $111,000
Q3 2019

Nov 06, 2019

SELL
$106.79 - $116.16 $18,688 - $20,328
-175 Reduced 22.29%
610 $68,000
Q2 2019

Aug 14, 2019

SELL
$110.79 - $129.32 $14,402 - $16,811
-130 Reduced 14.21%
785 $87,000
Q1 2019

May 13, 2019

BUY
$111.31 - $131.02 $101,848 - $119,883
915 New
915 $119,000
Q1 2019

May 03, 2019

SELL
$111.31 - $131.02 $129,008 - $151,852
-1,159 Closed
0 $0
Q4 2018

Feb 01, 2019

BUY
$105.9 - $118.64 $10,590 - $11,864
100 Added 9.44%
1,159 $134,000
Q3 2018

Oct 29, 2018

BUY
$85.86 - $107.31 $12,707 - $15,881
148 Added 16.25%
1,059 $113,000
Q2 2018

Aug 03, 2018

SELL
$75.7 - $86.88 $217,940 - $250,127
-2,879 Reduced 75.96%
911 $78,000
Q1 2018

Apr 23, 2018

BUY
$74.21 - $87.6 $197,398 - $233,015
2,660 Added 235.4%
3,790 $293,000
Q4 2017

Feb 12, 2018

SELL
$81.94 - $87.89 $9,505 - $10,195
-116 Reduced 9.31%
1,130 $96,000
Q3 2017

Nov 01, 2017

BUY
$77.07 - $85.54 $96,029 - $106,582
1,246
1,246 $107,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Financial Architects, Inc Portfolio

Follow Financial Architects, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Architects, Inc with notifications on news.